Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

12.31
Delayed Data
As of Sep 30
 +0.01 / +0.08%
Today’s Change
9.59
Today|||52-Week Range
22.11
-28.80%
Year-to-Date
No recent news for Sucampo Pharmaceuticals Inc.

Today’s Trading

Previous close12.30
Today’s open12.34
Day’s range12.07 - 12.52
Volume291,483
Average volume (3 months)375,901
Market cap$564.1M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+8.15%
Earnings growth (next 5 years)+55.50%
Revenue growth (last year)+32.68%
P/E ratio45.6
Price/Sales5.16
Price/Book6.48

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.16+3.11%
LOXOLoxo Oncology Inc+0.71+2.79%
CTMXCytomX Therapeutics ...+0.15+0.97%
OTICOtonomy Inc+0.93+5.39%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts

Search for Jobs